BIOXINESS PHARMACEUTICALS, INC. — Form D/A
BIOXINESS PHARMACEUTICALS, INC. of HERCULES, CA, a company, filed a Form D amendment with the SEC on 2011-01-20. The offering totals $2.0M, of which $303K was reported sold. Industry: Pharmaceuticals.
Offering
- Filed: 2011-01-20
- Form: D/A
- Accession: 0001470930-11-000001
- Industry: Pharmaceuticals
- Exemptions: 06
- Total offering: $2.0M
- Amount sold: $303K
- Remaining: $1.7M
- Investors: 8
- Date of first sale: 2009-06-05
- Security types: debt
- Revenue range: Decline to Disclose
- SEC file number: 021-134194
Issuer
- Name: BIOXINESS PHARMACEUTICALS, INC.
- CIK: 0001470930
- Entity type: Corporation
- Jurisdiction: CALIFORNIA
- Incorporated: 2007
- Address: 750 ALFRED NOBEL DRIVE SUITE 106, HERCULES, CA, 94547
- Phone: 510 724 1548
Officers, directors & promoters (10)
| Name | Role | Location |
|---|
| Reza Ilkhani | Director | Hercules, CA |
| Clint H Severson | Director | Hercules, CA |
| Reza Ilkhani | Executive Officer | Hercules, CA |
| Susan Froshauer | Director | Farmington, CT |
| Clinton Severson | Director | Hercules, CA |
| Matthew Kerby | Director | Hercules, CA |
| Constance McKee | Director | Hercules, CA |
| Mansour Bassiri | Director | Hercules, CA |
| Mansour Bassiri | Executive Officer | Hercules, CA |
| Mansour Bassiri | Promoter | Hercules, CA |
Other filings by this issuer (2)
More